These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 12458337

  • 1. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
    Yoshimura C, Nomura S, Kanazawa S, Kuwana M, Muramatsu M, Yamaguchi K, Fukuhara S.
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
    [Abstract] [Full Text] [Related]

  • 2. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F.
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [Abstract] [Full Text] [Related]

  • 3. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
    Seki N, Hoshino T, Kikuchi M, Hayashi A, Itoh K.
    Cell Immunol; 1997 Feb 01; 175(2):101-10. PubMed ID: 9023415
    [Abstract] [Full Text] [Related]

  • 4. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL.
    Clin Cancer Res; 2002 Aug 01; 8(8):2553-62. PubMed ID: 12171883
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 01; 160(2):571-6. PubMed ID: 9679930
    [Abstract] [Full Text] [Related]

  • 6. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
    Erdoğan B, Uzaslan E, Budak F, Karadağ M, Ediger D, Oral B, Göral G, Ege E, Gözü O.
    Tuberk Toraks; 2005 Aug 01; 53(2):127-31. PubMed ID: 16100648
    [Abstract] [Full Text] [Related]

  • 7. Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancer.
    Yoshikawa T, Saito H, Osaki T, Matsumoto S, Tsujitani S, Ikeguchi M.
    J Surg Res; 2008 Aug 01; 148(2):143-51. PubMed ID: 18561948
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of sFas and sFasL during chemotherapy of lung cancer.
    Naumnik W, Izycki T, Ossolinska M, Chyczewska E.
    Exp Oncol; 2007 Jun 01; 29(2):132-6. PubMed ID: 17704746
    [Abstract] [Full Text] [Related]

  • 9. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL.
    Clin Cancer Res; 2005 Feb 01; 11(3):1010-20. PubMed ID: 15709166
    [Abstract] [Full Text] [Related]

  • 10. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S, Anfossi S, O'Brien TJ, Cannon MJ, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
    Cancer; 2009 Feb 15; 115(4):800-11. PubMed ID: 19117353
    [Abstract] [Full Text] [Related]

  • 11. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC.
    Oncol Rep; 2003 Feb 15; 10(1):57-63. PubMed ID: 12469145
    [Abstract] [Full Text] [Related]

  • 12. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis.
    Dick AD, Siepmann K, Dees C, Duncan L, Broderick C, Liversidge J, Forrester JV.
    Invest Ophthalmol Vis Sci; 1999 Sep 15; 40(10):2258-67. PubMed ID: 10476791
    [Abstract] [Full Text] [Related]

  • 13. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
    Imai K, Hirata S, Irie A, Senju S, Ikuta Y, Yokomine K, Harao M, Inoue M, Tsunoda T, Nakatsuru S, Nakagawa H, Nakamura Y, Baba H, Nishimura Y.
    Clin Cancer Res; 2008 Oct 15; 14(20):6487-95. PubMed ID: 18927288
    [Abstract] [Full Text] [Related]

  • 14. Generation of cytotoxic T lymphocytes against autologous lung cancer cells resistant to apoptosis.
    Hiraki A, Ono T, Tanaka M, Kiura K, Ueoka H, Kawai H, Harada M, Nakayama E, Noguchi Y.
    Anticancer Res; 2001 Oct 15; 21(4A):2561-7. PubMed ID: 11724322
    [Abstract] [Full Text] [Related]

  • 15. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct 15; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 16. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG.
    J Autoimmun; 1998 Oct 15; 11(5):457-63. PubMed ID: 9802929
    [Abstract] [Full Text] [Related]

  • 17. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC, Murray SL, Balakrishnan VS, Guo D, King AJ, Pereira BJ, Jaber BL.
    J Lab Clin Med; 2000 Oct 15; 136(4):320-7. PubMed ID: 11039853
    [Abstract] [Full Text] [Related]

  • 18. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S, Wehler T, Schnürer E, Lennerz V, Brenner W, Melchior S, Gröne M, Nonn M, Strand S, Meyer R, Ranieri E, Huber C, Falk CS, Herr W.
    Cancer Res; 2006 Dec 01; 66(23):11447-54. PubMed ID: 17145892
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients.
    Nikitina EY, Clark JI, Van Beynen J, Chada S, Virmani AK, Carbone DP, Gabrilovich DI.
    Clin Cancer Res; 2001 Jan 01; 7(1):127-35. PubMed ID: 11205900
    [Abstract] [Full Text] [Related]

  • 20. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X, Hazarika P, Zhang C, Talpur R, Duvic M.
    Clin Cancer Res; 2001 Sep 01; 7(9):2682-92. PubMed ID: 11555580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.